
Opinion|Videos|June 18, 2024
Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective
Medical experts discuss their perspectives on therapy approval and the significance of formulary inclusion, emphasizing the need to carefully consider both toxicities and benefits, which may ultimately lead to the operationalization of a drug in clinical practice.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
How will the potential approval of ribociclib for early breast cancer change your treatment paradigms?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pennsylvania Confirms First Measles Deaths in 35 Years as US Case Count Tops 2900
2
New Lipid Drugs and What Pharmacists Need to Know
3
FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options for Children
4
August 2026 in Oncology: FDA Approvals and Phase 3 Data Reshape Treatment Across Tumor Types
5




































































































